Capital World Investors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-841,900
| Closed | -$127M | – | 573 |
|
2022
Q3 | $127M | Sell |
841,900
-1,800,734
| -68% | -$272M | 0.03% | 312 |
|
2022
Q2 | $385M | Sell |
2,642,634
-3,999,905
| -60% | -$583M | 0.08% | 211 |
|
2022
Q1 | $788M | Buy |
6,642,539
+464,530
| +8% | +$55.1M | 0.14% | 167 |
|
2021
Q4 | $851M | Buy |
6,178,009
+115,628
| +2% | +$15.9M | 0.13% | 160 |
|
2021
Q3 | $842M | Buy |
6,062,381
+754
| +0% | +$105K | 0.14% | 159 |
|
2021
Q2 | $588M | Buy |
6,061,627
+1,321,691
| +28% | +$128M | 0.1% | 197 |
|
2021
Q1 | $324M | Buy |
4,739,936
+90,488
| +2% | +$6.18M | 0.06% | 242 |
|
2020
Q4 | $399M | Buy |
4,649,448
+1,340,473
| +41% | +$115M | 0.08% | 222 |
|
2020
Q3 | $215M | Buy |
3,308,975
+1,110,384
| +51% | +$72.2M | 0.05% | 259 |
|
2020
Q2 | $161M | Buy |
2,198,591
+737
| +0% | +$53.9K | 0.04% | 268 |
|
2020
Q1 | $74.8M | Buy |
2,197,854
+551,428
| +33% | +$18.8M | 0.02% | 296 |
|
2019
Q4 | $89.6M | Buy |
1,646,426
+1,176,426
| +250% | +$64M | 0.02% | 315 |
|
2019
Q3 | $19.6M | Hold |
470,000
| – | – | ﹤0.01% | 410 |
|
2019
Q2 | $20.6M | Buy |
+470,000
| New | +$20.6M | ﹤0.01% | 437 |
|